|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 3.310 USD | -0.90% |
|
3.525 | +6.50% |
| Market Cap | 1.77B 1.55B 1.43B 1.31B 2.49B 171B 2.53B 17.07B 6.7B 83.37B 6.66B 6.51B 287B | P/E 2026 * |
-3.8x | P/E 2027 * | -3.54x |
|---|---|---|---|---|---|
| Enterprise Value | 1.33B 1.16B 1.07B 986M 1.87B 128B 1.9B 12.8B 5.02B 62.53B 4.99B 4.88B 216B | EV / Sales 2026 * |
20.5x | EV / Sales 2027 * | 17.8x |
| Free-Float |
96.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Recursion Pharmaceuticals, Inc.
| 1 day | -0.90% | ||
| 1 week | -11.02% | ||
| Current month | -9.81% | ||
| 1 month | +0.61% | ||
| 3 months | -11.73% | ||
| 6 months | -28.66% | ||
| Current year | -19.07% |
| 1 week | 3.2 |  | 3.8 |
| 1 month | 3.07 | | 4.09 |
| Current year | 2.77 | | 5.24 |
| 1 year | 2.77 | | 7.18 |
| 3 years | 2.77 | | 16.74 |
| 5 years | 2.77 | | 37.61 |
| 10 years | 2.77 | | 42.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Najat Khan
CEO | Chief Executive Officer | 43 | 2025-12-31 |
Ben Taylor
DFI | Director of Finance/CFO | 48 | 2024-11-19 |
Sid Jain
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Blake Borgeson
BRD | Director/Board Member | 44 | 2013-11-03 |
Dean Li
BRD | Director/Board Member | 62 | 2013-11-03 |
Zavain Dar
BRD | Director/Board Member | 37 | 2016-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-06 | Sell | Founder | -40,000 | 0.0076% | ||
| 06-30 | Free | Founder | 3,747 | 0.0007% | ||
| 06-30 | Free | Director | 5,109 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -11.02% | -36.59% | -72.18% | 1.77B | |
| -1.39% | -6.15% | +56.05% | +124.73% | 54.49B | |
| +3.13% | +13.95% | +64.21% | +94.35% | 55.93B | |
| -0.27% | -5.77% | +6.75% | +433.06% | 23.87B | |
| +1.76% | -1.65% | -16.86% | -15.01% | 22.86B | |
| +3.51% | +10.88% | +44.84% | -3.33% | 20B | |
| +1.94% | +0.21% | +39.31% | -27.77% | 17.48B | |
| +10.00% | -4.30% | +208.33% | +370.99% | 15.39B | |
| +7.69% | +11.91% | +50.03% | +712.88% | 15.19B | |
| -0.39% | -1.00% | +26.08% | +186.49% | 14.02B | |
| Average | +2.51% | -0.74% | +44.21% | +180.42% | 24.1B | |
| Weighted average by Cap. | +2.08% | +0.40% | +50.92% | +168.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 64.74M 56.6M 52.21M 48M 90.94M 6.23B 92.5M 623M 245M 3.04B 243M 238M 10.49B | 83.76M 73.23M 67.56M 62.1M 118M 8.06B 120M 807M 316M 3.94B 315M 308M 13.58B |
| Net income | -453M -396M -366M -336M -637M -43.61B -648M -4.36B -1.71B -21.32B -1.7B -1.66B -73.47B | -525M -459M -423M -389M -737M -50.51B -750M -5.05B -1.98B -24.69B -1.97B -1.93B -85.09B |
| Net Debt | -443M -388M -358M -329M -623M -42.65B -633M -4.27B -1.67B -20.85B -1.66B -1.63B -71.86B | -285M -249M -230M -212M -401M -27.45B -408M -2.75B -1.08B -13.42B -1.07B -1.05B -46.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | US$3.310 | -0.90% | 19,388,772 |
| 26-07-14 | US$3.340 | +1.21% | 25,658,546 |
| 26-07-13 | US$3.300 | -7.30% | 24,497,736 |
| 26-07-10 | US$3.560 | -5.32% | 20,808,232 |
| 26-07-09 | US$3.760 | +1.08% | 22,293,569 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RXRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
